Gender differences in non-adherence among Brazilian patients initiating antiretroviral therapy

Detalhes bibliográficos
Autor(a) principal: de Fatima Bonolo, Palmira
Data de Publicação: 2013
Outros Autores: Ceccato, Maria das Graças Braga, Rocha, Gustavo Machado, de Assis Acúrcio, Francisco, Campos, Lorenza Nogueira, Guimarães, Mark Drew Crosland
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Clinics
Texto Completo: https://www.revistas.usp.br/clinics/article/view/76836
Resumo: OBJECTIVE: We conducted a study to identify gender differences in factors associated with the first episode of non-adherence in the 12 months following the first antiretroviral prescription. METHODS: A concurrent prospective study of patients initiating antiretroviral therapy in Brazil was conducted from 2001-2002. The self-reported measurement of adherence was defined as an intake of less than 95% of the prescribed number of doses. Only the first occurrence of non-adherence was considered in this analysis. All analyses were stratified by gender. A Cox proportional hazard model was used to estimate the risk of non-adherence, and the time to non-adherence was estimated using the Kaplan-Meier method. RESULTS: The cumulative incidence of non-adherence was 34.6% (29.7% and 43.9% among men and women, respectively; p=0.010). Marital status (being married or in stable union; p=0.022), alcohol use in the month prior to the baseline interview (p=0.046), and current tobacco use (p=0.005) increased the risk of non-adherence among female participants only, whereas a self-reported difficulty with the antiretroviral treatment was associated with non-adherence in men only. For both men and women, we found that a longer time between the HIV test and first antiretroviral therapy prescription (p=0.028) also presented an increased risk of non-adherence. CONCLUSIONS: In this cohort study, the incidence of non-adherence was 1.5 times greater among women compared to men. Our results reinforce the need to develop interventions that account for gender differences in public referral centers. Additionally, we emphasize that, to achieve and maintain appropriate adherence levels, it is important to understand the barriers to seeking and utilizing health care services.
id USP-19_fcf23af89135fec85049b29b2782e505
oai_identifier_str oai:revistas.usp.br:article/76836
network_acronym_str USP-19
network_name_str Clinics
repository_id_str
spelling Gender differences in non-adherence among Brazilian patients initiating antiretroviral therapyOBJECTIVE: We conducted a study to identify gender differences in factors associated with the first episode of non-adherence in the 12 months following the first antiretroviral prescription. METHODS: A concurrent prospective study of patients initiating antiretroviral therapy in Brazil was conducted from 2001-2002. The self-reported measurement of adherence was defined as an intake of less than 95% of the prescribed number of doses. Only the first occurrence of non-adherence was considered in this analysis. All analyses were stratified by gender. A Cox proportional hazard model was used to estimate the risk of non-adherence, and the time to non-adherence was estimated using the Kaplan-Meier method. RESULTS: The cumulative incidence of non-adherence was 34.6% (29.7% and 43.9% among men and women, respectively; p=0.010). Marital status (being married or in stable union; p=0.022), alcohol use in the month prior to the baseline interview (p=0.046), and current tobacco use (p=0.005) increased the risk of non-adherence among female participants only, whereas a self-reported difficulty with the antiretroviral treatment was associated with non-adherence in men only. For both men and women, we found that a longer time between the HIV test and first antiretroviral therapy prescription (p=0.028) also presented an increased risk of non-adherence. CONCLUSIONS: In this cohort study, the incidence of non-adherence was 1.5 times greater among women compared to men. Our results reinforce the need to develop interventions that account for gender differences in public referral centers. Additionally, we emphasize that, to achieve and maintain appropriate adherence levels, it is important to understand the barriers to seeking and utilizing health care services.Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo2013-05-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://www.revistas.usp.br/clinics/article/view/7683610.1590/clin.v68i5.76836Clinics; v. 68 n. 5 (2013); 612-620Clinics; Vol. 68 Núm. 5 (2013); 612-620Clinics; Vol. 68 No. 5 (2013); 612-6201980-53221807-5932reponame:Clinicsinstname:Universidade de São Paulo (USP)instacron:USPenghttps://www.revistas.usp.br/clinics/article/view/76836/80698de Fatima Bonolo, PalmiraCeccato, Maria das Graças BragaRocha, Gustavo Machadode Assis Acúrcio, FranciscoCampos, Lorenza NogueiraGuimarães, Mark Drew Croslandinfo:eu-repo/semantics/openAccess2014-03-21T19:31:25Zoai:revistas.usp.br:article/76836Revistahttps://www.revistas.usp.br/clinicsPUBhttps://www.revistas.usp.br/clinics/oai||clinics@hc.fm.usp.br1980-53221807-5932opendoar:2014-03-21T19:31:25Clinics - Universidade de São Paulo (USP)false
dc.title.none.fl_str_mv Gender differences in non-adherence among Brazilian patients initiating antiretroviral therapy
title Gender differences in non-adherence among Brazilian patients initiating antiretroviral therapy
spellingShingle Gender differences in non-adherence among Brazilian patients initiating antiretroviral therapy
de Fatima Bonolo, Palmira
title_short Gender differences in non-adherence among Brazilian patients initiating antiretroviral therapy
title_full Gender differences in non-adherence among Brazilian patients initiating antiretroviral therapy
title_fullStr Gender differences in non-adherence among Brazilian patients initiating antiretroviral therapy
title_full_unstemmed Gender differences in non-adherence among Brazilian patients initiating antiretroviral therapy
title_sort Gender differences in non-adherence among Brazilian patients initiating antiretroviral therapy
author de Fatima Bonolo, Palmira
author_facet de Fatima Bonolo, Palmira
Ceccato, Maria das Graças Braga
Rocha, Gustavo Machado
de Assis Acúrcio, Francisco
Campos, Lorenza Nogueira
Guimarães, Mark Drew Crosland
author_role author
author2 Ceccato, Maria das Graças Braga
Rocha, Gustavo Machado
de Assis Acúrcio, Francisco
Campos, Lorenza Nogueira
Guimarães, Mark Drew Crosland
author2_role author
author
author
author
author
dc.contributor.author.fl_str_mv de Fatima Bonolo, Palmira
Ceccato, Maria das Graças Braga
Rocha, Gustavo Machado
de Assis Acúrcio, Francisco
Campos, Lorenza Nogueira
Guimarães, Mark Drew Crosland
description OBJECTIVE: We conducted a study to identify gender differences in factors associated with the first episode of non-adherence in the 12 months following the first antiretroviral prescription. METHODS: A concurrent prospective study of patients initiating antiretroviral therapy in Brazil was conducted from 2001-2002. The self-reported measurement of adherence was defined as an intake of less than 95% of the prescribed number of doses. Only the first occurrence of non-adherence was considered in this analysis. All analyses were stratified by gender. A Cox proportional hazard model was used to estimate the risk of non-adherence, and the time to non-adherence was estimated using the Kaplan-Meier method. RESULTS: The cumulative incidence of non-adherence was 34.6% (29.7% and 43.9% among men and women, respectively; p=0.010). Marital status (being married or in stable union; p=0.022), alcohol use in the month prior to the baseline interview (p=0.046), and current tobacco use (p=0.005) increased the risk of non-adherence among female participants only, whereas a self-reported difficulty with the antiretroviral treatment was associated with non-adherence in men only. For both men and women, we found that a longer time between the HIV test and first antiretroviral therapy prescription (p=0.028) also presented an increased risk of non-adherence. CONCLUSIONS: In this cohort study, the incidence of non-adherence was 1.5 times greater among women compared to men. Our results reinforce the need to develop interventions that account for gender differences in public referral centers. Additionally, we emphasize that, to achieve and maintain appropriate adherence levels, it is important to understand the barriers to seeking and utilizing health care services.
publishDate 2013
dc.date.none.fl_str_mv 2013-05-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://www.revistas.usp.br/clinics/article/view/76836
10.1590/clin.v68i5.76836
url https://www.revistas.usp.br/clinics/article/view/76836
identifier_str_mv 10.1590/clin.v68i5.76836
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv https://www.revistas.usp.br/clinics/article/view/76836/80698
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo
publisher.none.fl_str_mv Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo
dc.source.none.fl_str_mv Clinics; v. 68 n. 5 (2013); 612-620
Clinics; Vol. 68 Núm. 5 (2013); 612-620
Clinics; Vol. 68 No. 5 (2013); 612-620
1980-5322
1807-5932
reponame:Clinics
instname:Universidade de São Paulo (USP)
instacron:USP
instname_str Universidade de São Paulo (USP)
instacron_str USP
institution USP
reponame_str Clinics
collection Clinics
repository.name.fl_str_mv Clinics - Universidade de São Paulo (USP)
repository.mail.fl_str_mv ||clinics@hc.fm.usp.br
_version_ 1787713176573313024